<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0221013" disease_type="Disease or Syndrome" abbrv="">Systemic mast cell disease</z:e> (SMCD) cannot be distinguished from reactive <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> (RM) by quantitation of mast cells in aspirate smears, and few studies have analyzed systematically the morphologic features of mast cells in SMCD vs RM </plain></SENT>
<SENT sid="1" pm="."><plain>In addition, although SMCD is associated with <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo>/<z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MPD/MDS</z:e>), it is not known whether subtle signs of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e> can be found in SMCD, suggesting most cases are part of a dysplastic or myeloproliferative process </plain></SENT>
<SENT sid="2" pm="."><plain>We compared 18 bone marrow specimens with SMCD with 10 bone marrow specimens from patients with RM </plain></SENT>
<SENT sid="3" pm="."><plain>Mast cells in SMCD were more likely to show cytoplasmic hypogranularity, uneven granule distribution, and fusiform morphologic features </plain></SENT>
<SENT sid="4" pm="."><plain>Eight cases of SMCD (44%) demonstrated <z:e sem="disease" ids="C1301355" disease_type="Neoplastic Process" abbrv="">MPD/MDS</z:e>, and 9 cases (50%) showed subtle evidence of dyspoiesis, with <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> change, nuclear budding of erythroid precursors, and/or atypical megakaryocytes </plain></SENT>
<SENT sid="5" pm="."><plain>Mast cells in SMCD appear morphologically different from those in reactive proliferations </plain></SENT>
<SENT sid="6" pm="."><plain>Dyspoietic features were present in most cases of SMCD, suggesting that SMCD is part of a spectrum of <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloproliferative/<z:mpath ids='MPATH_341'>myelodysplastic disorders</z:mpath> </plain></SENT>
</text></document>